Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System

Remdesivir was recommended for hospitalized patients with COVID-19. As already reported in the Summary of Product Characteristics, most of remdesivir’s safety concerns are hepatoxicity and nephrotoxicity related. However, some cases have raised concerns regarding the potential cardiac events associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafaniello, Concetta, Ferrajolo, Carmen, Sullo, Maria Giuseppa, Gaio, Mario, Zinzi, Alessia, Scavone, Cristina, Gargano, Francesca, Coscioni, Enrico, Rossi, Francesco, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308754/
https://www.ncbi.nlm.nih.gov/pubmed/34202350
http://dx.doi.org/10.3390/ph14070611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308754/
https://www.ncbi.nlm.nih.gov/pubmed/34202350
http://dx.doi.org/10.3390/ph14070611

Ejemplares similares